TY - JOUR
T1 - Primary plasma cell leukemia
T2 - autologous stem cell transplant in an era of novel induction drugs
AU - Gowda, Lohith
AU - Shah, Mithun
AU - Badar, Ifra
AU - Bashir, Qaiser
AU - Shah, Nina
AU - Patel, Krina
AU - Kanagal-Shamanna, Rashmi
AU - Mehta, Rohtesh
AU - Weber, Donna M.
AU - Lee, Hans C.
AU - Manasanch, Elisabet E.
AU - Shah, Abdul
AU - Thomas, Sheeba K.
AU - Parmar, Simrit
AU - Nieto, Yago
AU - Orlowski, Robert Z.
AU - Champlin, Richard
AU - Qazilbash, Muzaffar H.
N1 - Publisher Copyright:
© 2018, Springer Nature Limited.
PY - 2019/7/1
Y1 - 2019/7/1
N2 - Primary plasma cell leukemia (pPCL) is a rare and aggressive variant of multiple myeloma (MM) with poor long-term survival after cytotoxic chemotherapy. Many novel drugs have revolutionized the treatment algorithms for MM. The impact of targeted therapy, both pre- and post-autologous stem cell transplant (auto-HCT) remains an area of ongoing interest. In this study, we report outcomes post auto-HCT for pPCL and the impact of maintenance therapy posttransplant with novel agents.
AB - Primary plasma cell leukemia (pPCL) is a rare and aggressive variant of multiple myeloma (MM) with poor long-term survival after cytotoxic chemotherapy. Many novel drugs have revolutionized the treatment algorithms for MM. The impact of targeted therapy, both pre- and post-autologous stem cell transplant (auto-HCT) remains an area of ongoing interest. In this study, we report outcomes post auto-HCT for pPCL and the impact of maintenance therapy posttransplant with novel agents.
UR - http://www.scopus.com/inward/record.url?scp=85056786502&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056786502&partnerID=8YFLogxK
U2 - 10.1038/s41409-018-0392-1
DO - 10.1038/s41409-018-0392-1
M3 - Article
C2 - 30446740
AN - SCOPUS:85056786502
SN - 0268-3369
VL - 54
SP - 1089
EP - 1093
JO - Bone marrow transplantation
JF - Bone marrow transplantation
IS - 7
ER -